The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO GI 2023 | Is short-course radiation the best course of therapy in rectal cancer?
Paul Bernard Romesser, MD, Memorial Sloan Kettering Cancer Center, New York, NY, talks on concerns regarding the use of short-course radiation in patients with rectal cancer. Whilst short-course radiation improved outcomes in the Phase III RAPIDO trial (NCT01558921), further studies suggests bowel function is worse in these group of patients, despite higher rates of organ preservation. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Gastrointestinal Cancers (GI) Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
